US4401662A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
Assignee: Choay SA
•
Filing: 1980-10-06
•
Granted: 1983-08-30
•
Expires: 2000-10-06
Abstract
Abstract Oligosaccharides obtainable from heparin including heparinic constituents of molecular weights ranging from 2000 to 50,000. Said fractions have a Yin-Wessler titer and a USP titer in a ratio of at least 30. They consist of chains constituted by no more than 8 saccharidic moities. They possess a strong antithrombotic activity and are then useful as antithrombotic drugs.
Inventors
- 👤 Jean-Claude Lormeau
- 👤 Jean Choay
- 👤 Maurice Petitou
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:18
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; A; A61; A61P; A61P7/00; A61P7/02
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
95 words
An oligosaccharide fraction of the heparin chain which oligosaccharide has improved antithrombotic activity in vivo higher than that of heparin (as measured by the Yin-Wessler test), which oligosaccharide fraction (1) comprises not more than 8 saccharide units, (2) of which one is an N-sulfate-3-O-sulfate-D-glucosamine unit (3) has anti-Xa activity at least 10 times that of heparin, (4) specific affinity for AT III, (5) a ratio of Yin-Wessler titer to USP titer of at least 30 and (6) virtually no anticoagulant activity (as determined by the USP test) and, the biologically acceptable salts of said oligosaccharide.
Claim 2
Dependent Claim
95 words
An oligosaccharide fraction of the heparin chain which oligosaccharide has improved antithrombotic activity in vivo higher than that of heparin (as measured by the Yin-Wessler test), which oligosaccharide fraction (1) comprises not more than 8 saccharide units, (2) of which one is an N-sulfate-3-O-sulfate-D-glucosamine unit (3) has anti-Xa activity at least 10 times that of heparin, (4) specific affinity for AT III, (5) a ratio of Yin-Wessler titer to USP titer of at least 30 and (6) virtually no anticoagulant activity (as determined by the USP test) and, the biologically acceptable salts of said oligosaccharide.
Claim 3
Dependent Claim
73 words
The oligosaccharide of claim 1 which oligosaccharide contains a saccharide sequence of units selected from the group consisting of ABCDEFGH, ABGHCDEF, ABCDEF, CDEFGH and DEFGH, wherein A, B, C, D, E, F, G and H are defined as follows A=unsaturated or saturated uronic acid B=N-sulfate-D-Glucosamine or N-sulfate-6-O-sulfate-D-glucosamine C=L-iduronic acid or, where present at a chain end, unsaturated uronic acid D=N-acetyl-D-glucosamine or N-acetyl-6-O-sulfate-D-glucosamine E=D-glucuronic acid F=N-sulfate-3-O-sulfate-D-glucosamine or N-sulfate-3-O-sulfate-6-O-sulfate-D-glucosamine G=2-O-sulfate-L-iduronic acid, and H=N-sulfate-D-glucosamine or N-sulfate-6-O-sulfate-D-glucosamine.
Claim 4
Dependent Claim
10 words
The oligosaccharide of claim 1 wherein the N-sulfate-D-glucosamine is N-sulfate-3-O-sulfate-6-O-sulfate-D-glucosamine.
Claim 5
Dependent Claim
22 words
The oligosaccharide of claim 1 which includes a unit selected from the group consisting of N-acetyl-D-glucosamine, D-glucuronic acid, 2-O-sulfate-L-iduronic acid or N-sulfate-D-glucosamine.
Claim 6
Dependent Claim
23 words
The oligosaccharide of claim 1 which includes a unit selected from the group consisting of 2-O-sulfate-4,5 unsaturated uronic acid, N-sulfate-D-glucosamine or L-iduronic acid.
Claim 7
Dependent Claim
22 words
The oligosaccharide of claim 1 which includes a unit selected from the group consisting of N-sulfate-6-O-sulfate-D-glucosamine, L-iduronic acid, 2-O-sulfate-L-iduronic acid or N-sulfate-D-glucosamine.
Claim 8
Dependent Claim
19 words
The oligosaccharide of claim 2 wherein the saccharide sequence is selected from the group consisting of CDEFGH or ABCDEF.
Claim 9
Dependent Claim
17 words
The oligosaccharide of claim 2 wherein the saccharide sequence is selected from the group consisting of DEFGH.
Claim 10
Dependent Claim
13 words
The oligosaccharide of claim 1 which is the sodium, calcium or magnesium salt.
Claim 11
Dependent Claim
18 words
The oligosaccharide of claim 1 wherein the N-sulfate-D-glucosamine unit is at the reducing end of the oligosaccharide chain.
Claim 12
Dependent Claim
19 words
The oligosaccharide of claim 1 which comprises one N-acetyl-glucosamine saccharide moiety for every two or three N-sulfate-glucosamine saccharide moieties.
Claim 13
Dependent Claim
48 words
A therapeutic antithrombotic composition which has antithrombotic activity higher than that of heparin (as measured by the Yin-Wessler test) which composition comprises a therapeutically acceptable carrier and in a therapeutically effective amount, an oligosaccharide of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11.
Claim 14
Dependent Claim
21 words
The therapeutic composition of claim 12 in which the ratio of Yin-Wessler titer to USP titer is at least about 100.
Claim 15
Dependent Claim
20 words
The therapeutic composition of claim 12 in which the oligosaccharide has a Yin-Wessler titer of 100 to about 2,000 U/mg.
Claim 16
Dependent Claim
25 words
A therapeutic method for controlling thrombosis in a patient which comprises administering to said patient the therapeutic antithrombotic composition of claim 12 and controlling thrombosis.
Claim 17
Dependent Claim
17 words
The therapeutic method of claim 15 in which the administration of the composition is at periodic intervals.
References Cited (Backward Citations)
US3506642A
Cited
US3985871A
Cited
US4213962A
Cited
GB2002406A
Cited
US4122250A
Cited
US4175182A
Cited
US4281108A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-08-29 | 1987-02-28 | 1987-08-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-08-29 | 1991-02-28 | 1991-08-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-08-29 | 1995-02-28 | 1995-08-30 | $7700.00 | Window Closed / Lapsed |